SCHEMBL465682

SCHEMBL465682

COC(=O)c1ccc(CC[Te]C)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 2/20 0.62
CYP4F2 P78329 1/20 0.60
LOXL2 Q9Y4K0 1/20 0.58
ALDH1A1 P00352 3/20 0.51
HPGD P15428 2/20 0.51
HSD17B10 Q99714 2/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
ALOX15 P16050 1/20 0.51
ALOX12 P18054 1/20 0.51
CYP2C19 P33261 1/20 0.51
CKS1B P61024 1/20 0.51
SKP2 Q13309 1/20 0.51
HIF1A Q16665 1/20 0.51
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
MAPT P10636 2/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70185 0.85 CYP4A11 (0.75) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL1643935 0.81 CYP4A11 (0.66) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL465729 0.81 LOXL2 (0.61) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL1807631 0.79 CYP4A11 (0.68) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL465781 0.79 KMT2A (0.57) ALDH1A1HPGDHSD17B10MAPTKMT2A
SCHEMBL8867548 0.79 CYP4A11 (0.68) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL1426157 0.79 CYP4A11 (0.68) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL2655571 0.79 CYP4A11 (0.79) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL28800126 0.79 CYP4A11 (0.68) CYP4A11CYP4F2LOXL2ALDH1A1HPGD
SCHEMBL465604 0.79 MAPT (0.48) ALDH1A1HPGDMAPTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024190876-A1 DOUBLE-SIDED ADHESIVE TAPE 積水化学工業株式会社 2024-09-19 WO disclosed
US-20200239743-A1 OPTICAL ADHESIVE LAYER, MANUFACTURING METHOD OF OPTICAL ADHESIVE LAYER, OPTICAL FILM WITH ADHESIVE LAYER, AND IMAGE DISPLAY DEVICE NITTO DENKO CORPORATION (JP) 2020-07-30 US disclosed
US-20200032116-A1 POLARIZING FILM ADHESIVE COMPOSITION, MANUFACTURING METHOD OF POLARIZING FILM ADHESIVE LAYER, POLARIZING FILM WITH ADHESIVE LAYER, AND IMAGE DISPLAY DEVICE NITTO DENKO CORPORATION (JP) 2020-01-30 US disclosed
US-20200032114-A1 OPTICAL ADHESIVE LAYER, MANUFACTURING METHOD OF OPTICAL ADHESIVE LAYER, OPTICAL FILM WITH ADHESIVE LAYER, AND IMAGE DISPLAY DEVICE NITTO DENKO CORPORATION (JP) 2020-01-30 US disclosed
US-20200032113-A1 OPTICAL ADHESIVE LAYER, MANUFACTURING METHOD OF OPTICAL ADHESIVE LAYER, OPTICAL FILM WITH ADHESIVE LAYER, AND IMAGE DISPLAY DEVICE NITTO DENKO CORPORATION (JP) 2020-01-30 US disclosed
US-20190225842-A1 OPTICAL ADHESIVE LAYER, MANUFACTURING METHOD OF OPTICAL ADHESIVE LAYER, OPTICAL FILM WITH ADHESIVE LAYER, AND IMAGE DISPLAY DEVICE NITTO DENKO CORPORATION (JP) 2019-07-25 US disclosed
US-10131824-B2 Adhesive composition, adhesive sheet, and method for producing semiconductor device LINTEC CORPORATION (JP) 2018-11-20 US disclosed
EP-2821817-B1 LAMINATE SHARP KK (JP) 2018-06-20 EP disclosed
US-9862167-B2 Laminate including antireflective moth-eye film and protection film SHARP KABUSHIKI KAISHA (JP) 2018-01-09 US disclosed
US-20160160094-A1 Adhesive Composition, Adhesive Sheet, and Method for Producing Semiconductor Device LINTEC CORPORATION (JP) 2016-06-09 US disclosed
US-20070073015-A1 Polymer, a method for producing the polymer, and a cement admixture using the same NIPPON SHOKUBAI CO., LTD. (JP) 2007-03-29 US disclosed
EP-1767564-A2 Polymer, a method for producing the polymer, and a cement admixture using the same NIPPON SHOKUBAI CO., LTD. (JP) 2007-03-28 EP disclosed
US-20060199927-A1 Process for production of living-radical polymers and polymers Outdoor Wireless Networks LLC 2006-09-07 US disclosed
US-20060167199-A1 Process for produciton of living radical polymers and polymers OTSUKA CHEMICAL CO., LTD. (JP) 2006-07-27 US disclosed
US-20060135711-A1 Process for the production of living radical polymers and polymers OTSUKA CHEMICAL CO., LTD. (JP) 2006-06-22 US disclosed
EP-1619211-A1 PROCESS FOR PRODUCTION OF LIVING-RADICAL POLYMERS AND POLYMERS OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2006-01-25 EP disclosed
EP-1595894-A1 PROCESS FOR THE PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2005-11-16 EP disclosed
US-20050245714-A1 Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2005-11-03 US disclosed
EP-1541550-A1 ORGANIC TELLURIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH THE SAME, AND POLYMER Otsuka Chemical Co., Ltd. (JP) 2005-06-15 EP disclosed
EP-1541592-A1 PROCESS FOR PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245714-A1 Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer ODC1, TERB1, TTI1 CYP4A11 2558/4885CYP4F2 1951/4885LOXL2 444/4885
US-20060135711-A1 Process for the production of living radical polymers and polymers CBR3, CBR1, CCNT1 CYP4A11 731/4885CYP4F2 243/4885LOXL2 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.